Stock SALR SALUS, LJUBLJANA, D. D.
Add to a list
To use this feature you must be a member
Log inSign up

Financials SALUS, Ljubljana, d. d.

Equities

SALR

SI0031110453

Drug Retailers

End-of-day quote Ljubljana S.E.
Other stock markets
 06:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
1,990 EUR -2.45% Intraday chart for SALUS, Ljubljana, d. d. -2.45% +10.56%
Feb. 28 SALUS, Ljubljana, d. d. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jan. 09 SALUS, Ljubljana, d. d. cancelled the acquisition of Farmadent S.R.L. CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 60.55 72.02 93.94 148.2 145.1 189.7
Enterprise Value (EV) 1 60.68 72.77 98.21 143 142 189.1
P/E ratio 14.1 x 12.2 x 9.27 x 11.4 x 11.1 x 18.4 x
Yield 6.17% 6.52% 6.11% 4.58% 5.04% 3.89%
Capitalization / Revenue 0.24 x 0.21 x 0.23 x 0.32 x 0.29 x 0.32 x
EV / Revenue 0.24 x 0.21 x 0.25 x 0.31 x 0.29 x 0.32 x
EV / EBITDA 8.93 x 6.88 x 6.96 x 8.06 x 8.81 x 11.3 x
EV / FCF -8.18 x 18.2 x -87.4 x 10.7 x 21.7 x 17.4 x
FCF Yield -12.2% 5.48% -1.14% 9.35% 4.6% 5.75%
Price to Book 1.2 x 1.32 x 1.56 x 2.2 x 1.96 x 2.45 x
Nbr of stocks (in thousands) 101 104 104 104 104 105
Reference price 2 600.0 690.0 900.0 1,420 1,390 1,800
Announcement Date 4/25/19 3/16/20 3/15/21 3/4/22 3/13/23 2/28/24
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 253.2 348 400.7 458.3 495.7 599.4
EBITDA 1 6.793 10.58 14.12 17.76 16.12 16.71
EBIT 1 4.747 7.825 11.65 14.99 13.24 13.26
Operating Margin 1.88% 2.25% 2.91% 3.27% 2.67% 2.21%
Earnings before Tax (EBT) 1 5.348 7.474 12.6 16.37 16.41 13.09
Net income 1 4.291 5.903 10.13 13.01 13.1 10.27
Net margin 1.69% 1.7% 2.53% 2.84% 2.64% 1.71%
EPS 2 42.54 56.55 97.06 124.6 125.5 97.86
Free Cash Flow 1 -7.418 3.988 -1.123 13.37 6.538 10.86
FCF margin -2.93% 1.15% -0.28% 2.92% 1.32% 1.81%
FCF Conversion (EBITDA) - 37.69% - 75.31% 40.56% 65%
FCF Conversion (Net income) - 67.56% - 102.81% 49.93% 105.78%
Dividend per Share 2 37.00 45.00 55.00 65.00 70.00 70.00
Announcement Date 4/25/19 3/16/20 3/15/21 3/4/22 3/13/23 2/28/24
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 0.13 0.76 4.27 - - -
Net Cash position 1 - - - 5.17 3.06 0.59
Leverage (Debt/EBITDA) 0.0197 x 0.0714 x 0.3026 x - - -
Free Cash Flow 1 -7.42 3.99 -1.12 13.4 6.54 10.9
ROE (net income / shareholders' equity) 8.56% 11.2% 17.7% 20.4% 18.6% 13.6%
ROA (Net income/ Total Assets) 2.67% 3.71% 5.15% 5.94% 4.82% 4.25%
Assets 1 160.5 158.9 196.6 218.9 271.9 242
Book Value Per Share 2 499.0 523.0 575.0 645.0 708.0 736.0
Cash Flow per Share 2 131.0 137.0 84.50 169.0 183.0 215.0
Capex 1 0.39 1.21 3.25 4.05 2.25 5.72
Capex / Sales 0.15% 0.35% 0.81% 0.88% 0.45% 0.95%
Announcement Date 4/25/19 3/16/20 3/15/21 3/4/22 3/13/23 2/28/24
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Retail - Drugs without Grocery

1st Jan change Capi.
SALUS, LJUBLJANA, D. D. Stock SALUS, Ljubljana, d. d.
+10.56% 224M
RAIA DROGASIL S.A. Stock Raia Drogasil S.A.
-12.86% 8.57B
AIN HOLDINGS INC. Stock Ain Holdings Inc.
+32.95% 1.32B
QOL HOLDINGS CO., LTD. Stock Qol Holdings Co., Ltd.
+6.76% 419M
NIHON CHOUZAI CO.,LTD. Stock NIHON CHOUZAI Co.,Ltd.
+5.93% 282M
GREEN CROSS HEALTH LIMITED Stock Green Cross Health Limited
-8.26% 85.07M
PETMED EXPRESS, INC. Stock PetMed Express, Inc.
-46.83% 81.99M
MEDICAL IKKOU GROUP CO.,LTD. Stock Medical Ikkou Group Co.,Ltd.
+20.94% 59.57M
Retail - Drugs without Grocery
  1. Stock Market
  2. Equities
  3. SALR Stock
  4. Financials SALUS, Ljubljana, d. d.